Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Harvard Business School
UBS
Boehringer Ingelheim
Accenture
Deloitte
Medtronic
Healthtrust
Citi

Generated: January 18, 2018

DrugPatentWatch Database Preview

INSULIN SUSP ISOPHANE BEEF/PORK - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for insulin susp isophane beef/pork and what is the scope of insulin susp isophane beef/pork freedom to operate?

Insulin susp isophane beef/pork
is the generic ingredient in one branded drug marketed by Lilly and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for insulin susp isophane beef/pork.
Summary for INSULIN SUSP ISOPHANE BEEF/PORK

US Patents and Regulatory Information for INSULIN SUSP ISOPHANE BEEF/PORK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly NPH ILETIN I (BEEF-PORK) insulin susp isophane beef/pork INJECTABLE;INJECTION 017936-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly NPH ILETIN I (BEEF-PORK) insulin susp isophane beef/pork INJECTABLE;INJECTION 017936-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
Cipla
Healthtrust
Accenture
McKinsey
Moodys
AstraZeneca
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot